RuiXin Medical's AngioQFA Achieves Host-Level Integration with Leading Domestic DSA Systems, Ushering in a New Era of Precision Coronary Functional Assessment

Recently, the 2026 Medical Equipment Conference held in ChongqingUp,RaysightMed's self-developed one-stop coronary function macro + micro measurement system Angio QFA has successfully collaborated with domestically produced mainFlowDigital Subtraction Angiography (DSA)SetPreparation — Neusoft DSA Achieves Host-Level Embedded CollaborationBoth parties completed the full-process verification of signal transmission, image processing, data interaction, etc. in a real exhibition environment. The system operated stably, and all technical indicators met expectations.

This ValidationMarks the "native-level" system integration between China-produced AI innovative forces and mainstream DSA platforms, reshaping the technological ecosystem and clinical landscape for comprehensive coronary functional assessment., which also helps the DSA platform extend its value chain and intelligent boundaries in the era of precision intervention.

RaysightMed Announces Brand Upgrade: Using Intelligent Technology to Safeguard the Longer Rhythm of Life

Integration of Medicine and Engineering | RaysightMed Attends the Establishment Conference of Jinan University Heart Research Institute Alliance, Jointly Exploring the New Future of AI Empowered Cardiovascular Diagnosis and Treatment

RaysightMed Invited to Attend the Launch and Promotion Meeting of the National Key R&D Program Project "Key Technologies and Application Demonstration of Intelligent Cardiopulmonary Dynamics Simulation and Gas Exchange Simulation"